Skip to main content
Top
Published in: Cardiovascular Diabetology 1/2008

Open Access 01-12-2008 | Original investigation

Metabolic syndrome and risk of incident diabetes: findings from the European Prospective Investigation into Cancer and Nutrition-Potsdam Study

Authors: Earl S Ford, Matthias B Schulze, Tobias Pischon, Manuela M Bergmann, Hans-Georg Joost, Heiner Boeing

Published in: Cardiovascular Diabetology | Issue 1/2008

Login to get access

Abstract

Background

Several aspects concerning the relationship between the metabolic syndrome and incident diabetes are incompletely understood including the magnitude of the risk estimate, potential gender differences in the associations between the metabolic syndrome and incident diabetes, the associations between the components of the metabolic syndrome and incident diabetes, and whether the metabolic syndrome provides additional prediction beyond its components. To shed light on these issues, we examined the prospective association between the metabolic syndrome defined by the National Cholesterol Education Program (NCEP) and International Diabetes Federation (IDF) and diabetes.

Methods

We used data for 2796 men and women aged 35–65 years from the European Prospective Investigation into Cancer and Nutrition-Potsdam Study followed for an average of 6.9 years. This analysis employed a case-cohort design that included 697 participants who developed diabetes and 2099 participants who did not. Incident diabetes was identified on the basis of self-reports and verified by contacting the patient's attending physician.

Results

The adjusted hazard ratio for the NCEP definition was 4.62 (95% confidence interval [CI]: 3.90–5.48) and that for the IDF definition was 4.59 (95% CI: 3.84–5.50). The adjusted hazard ratios for the NCEP but not IDF definition were higher for women than men. When participants who had no cardiometabolic abnormalities were used as the reference group for the NCEP definition, the adjusted hazard ratio for having 3 or more abnormalities increased to 22.50 (95% CI: 11.21–45.19). Of the five components, abdominal obesity and hyperglycemia were most strongly associated with incident diabetes.

Conclusion

In this study population, both definitions of the metabolic syndrome provided similar estimates of relative risk for incident diabetes. The increase in risk for participants with the metabolic syndrome according to the NCEP definition was very large when contrasted with the risk among those who had no cardiometabolic abnormalities.
Appendix
Available only for authorised users
Literature
1.
go back to reference Kylin E: Studien uber das Hypertonie-Hyperglykamie-Hyperurikamiesyndrom. Zentralbl Inn Med. 1923, 44: 105-127. Kylin E: Studien uber das Hypertonie-Hyperglykamie-Hyperurikamiesyndrom. Zentralbl Inn Med. 1923, 44: 105-127.
2.
go back to reference Ford ES: Risks for all-cause mortality, cardiovascular disease, and diabetes associated with the metabolic syndrome: a summary of the evidence. Diabetes Care. 2005, 28: 1769-1778. 10.2337/diacare.28.7.1769.CrossRefPubMed Ford ES: Risks for all-cause mortality, cardiovascular disease, and diabetes associated with the metabolic syndrome: a summary of the evidence. Diabetes Care. 2005, 28: 1769-1778. 10.2337/diacare.28.7.1769.CrossRefPubMed
3.
go back to reference Kahn R, Buse J, Ferrannini E, Stern M: The metabolic syndrome: time for a critical appraisal: joint statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care. 2005, 28: 2289-2304. 10.2337/diacare.28.9.2289.CrossRefPubMed Kahn R, Buse J, Ferrannini E, Stern M: The metabolic syndrome: time for a critical appraisal: joint statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care. 2005, 28: 2289-2304. 10.2337/diacare.28.9.2289.CrossRefPubMed
4.
go back to reference Alberti KG, Zimmet P, Shaw J: Metabolic syndrome – a new world-wide definition. A Consensus Statement from the International Diabetes Federation. Diabet Med. 2006, 23: 469-480. 10.1111/j.1464-5491.2006.01858.x.CrossRefPubMed Alberti KG, Zimmet P, Shaw J: Metabolic syndrome – a new world-wide definition. A Consensus Statement from the International Diabetes Federation. Diabet Med. 2006, 23: 469-480. 10.1111/j.1464-5491.2006.01858.x.CrossRefPubMed
5.
go back to reference Hanley AJ, Karter AJ, Williams K, Festa A, D'Agostino RB, Wagenknecht LE, Haffner SM: Prediction of type 2 diabetes mellitus with alternative definitions of the metabolic syndrome: the Insulin Resistance Atherosclerosis Study. Circulation. 2005, 112: 3713-3721. 10.1161/CIRCULATIONAHA.105.559633.CrossRefPubMed Hanley AJ, Karter AJ, Williams K, Festa A, D'Agostino RB, Wagenknecht LE, Haffner SM: Prediction of type 2 diabetes mellitus with alternative definitions of the metabolic syndrome: the Insulin Resistance Atherosclerosis Study. Circulation. 2005, 112: 3713-3721. 10.1161/CIRCULATIONAHA.105.559633.CrossRefPubMed
6.
go back to reference Lorenzo C, Williams K, Hunt KJ, Haffner SM: The National Cholesterol Education Program – Adult Treatment Panel III, International Diabetes Federation, and World Health Organization definitions of the metabolic syndrome as predictors of incident cardiovascular disease and diabetes. Diabetes Care. 2007, 30: 8-13. 10.2337/dc06-1414.CrossRefPubMed Lorenzo C, Williams K, Hunt KJ, Haffner SM: The National Cholesterol Education Program – Adult Treatment Panel III, International Diabetes Federation, and World Health Organization definitions of the metabolic syndrome as predictors of incident cardiovascular disease and diabetes. Diabetes Care. 2007, 30: 8-13. 10.2337/dc06-1414.CrossRefPubMed
7.
go back to reference Meigs JB, Rutter MK, Sullivan LM, Fox CS, D'Agostino RB, Wilson PW: Impact of insulin resistance on risk of type 2 diabetes and cardiovascular disease in people with metabolic syndrome. Diabetes Care. 2007, 30: 1219-1225. 10.2337/dc06-2484.CrossRefPubMed Meigs JB, Rutter MK, Sullivan LM, Fox CS, D'Agostino RB, Wilson PW: Impact of insulin resistance on risk of type 2 diabetes and cardiovascular disease in people with metabolic syndrome. Diabetes Care. 2007, 30: 1219-1225. 10.2337/dc06-2484.CrossRefPubMed
8.
go back to reference Wang JJ, Li HB, Kinnunen L, Hu G, Jarvinen TM, Miettinen ME, Yuan S, Tuomilehto J: How well does the metabolic syndrome defined by five definitions predict incident diabetes and incident coronary heart disease in a Chinese population?. Atherosclerosis. 2007, 192: 161-168. 10.1016/j.atherosclerosis.2006.04.027.CrossRefPubMed Wang JJ, Li HB, Kinnunen L, Hu G, Jarvinen TM, Miettinen ME, Yuan S, Tuomilehto J: How well does the metabolic syndrome defined by five definitions predict incident diabetes and incident coronary heart disease in a Chinese population?. Atherosclerosis. 2007, 192: 161-168. 10.1016/j.atherosclerosis.2006.04.027.CrossRefPubMed
9.
go back to reference Cheung BM, Wat NM, Man YB, Tam S, Thomas GN, Leung GM, Cheng CH, Woo J, Janus ED, Lau CP, Lam TH, Lam KS: Development of diabetes in Chinese with the metabolic syndrome: a 6-year prospective study. Diabetes Care. 2007, 30: 1430-1436. 10.2337/dc06-1820.CrossRefPubMed Cheung BM, Wat NM, Man YB, Tam S, Thomas GN, Leung GM, Cheng CH, Woo J, Janus ED, Lau CP, Lam TH, Lam KS: Development of diabetes in Chinese with the metabolic syndrome: a 6-year prospective study. Diabetes Care. 2007, 30: 1430-1436. 10.2337/dc06-1820.CrossRefPubMed
10.
go back to reference Cameron AJ, Zimmet PZ, Soderberg S, Alberti KG, Sicree R, Tuomilehto J, Chitson P, Shaw JE: The metabolic syndrome as a predictor of incident diabetes mellitus in Mauritius. Diabet Med. 2007, 24: 1460-1469. 10.1111/j.1464-5491.2007.02288.x.CrossRefPubMed Cameron AJ, Zimmet PZ, Soderberg S, Alberti KG, Sicree R, Tuomilehto J, Chitson P, Shaw JE: The metabolic syndrome as a predictor of incident diabetes mellitus in Mauritius. Diabet Med. 2007, 24: 1460-1469. 10.1111/j.1464-5491.2007.02288.x.CrossRefPubMed
11.
go back to reference Cameron AJ, Magliano DJ, Zimmet PZ, Welborn TA, Colagiuri S, Tonkin AM, Shaw JE: The metabolic syndrome as a tool for predicting future diabetes: the AusDiab study. J Intern Med. 2008, 264: 177-186. 10.1111/j.1365-2796.2008.01935.x.CrossRefPubMed Cameron AJ, Magliano DJ, Zimmet PZ, Welborn TA, Colagiuri S, Tonkin AM, Shaw JE: The metabolic syndrome as a tool for predicting future diabetes: the AusDiab study. J Intern Med. 2008, 264: 177-186. 10.1111/j.1365-2796.2008.01935.x.CrossRefPubMed
12.
go back to reference Mannucci E, Monami M, Cresci B, Pala L, Bardini G, Petracca MG, Dicembrini I, Pasqua A, Buiatti E, Rotella CM: National Cholesterol Education Program and International Diabetes Federation definitions of metabolic syndrome in the prediction of diabetes: Results from the FIrenze-Bagno A Ripoli study. Diabetes Obes Metab. 2008, 10: 430-435. 10.1111/j.1463-1326.2007.00724.x.CrossRefPubMed Mannucci E, Monami M, Cresci B, Pala L, Bardini G, Petracca MG, Dicembrini I, Pasqua A, Buiatti E, Rotella CM: National Cholesterol Education Program and International Diabetes Federation definitions of metabolic syndrome in the prediction of diabetes: Results from the FIrenze-Bagno A Ripoli study. Diabetes Obes Metab. 2008, 10: 430-435. 10.1111/j.1463-1326.2007.00724.x.CrossRefPubMed
13.
go back to reference Hadaegh F, Ghasemi A, Padyab M, Tohidi M, Azizi F: The metabolic syndrome and incident diabetes: Assessment of alternative definitions of the metabolic syndrome in an Iranian urban population. Diabetes Res Clin Pract. 2008, 80: 328-334. 10.1016/j.diabres.2008.01.003.CrossRefPubMed Hadaegh F, Ghasemi A, Padyab M, Tohidi M, Azizi F: The metabolic syndrome and incident diabetes: Assessment of alternative definitions of the metabolic syndrome in an Iranian urban population. Diabetes Res Clin Pract. 2008, 80: 328-334. 10.1016/j.diabres.2008.01.003.CrossRefPubMed
14.
go back to reference Boeing H, Wahrendorf J, Becker N: EPIC-Germany – A source for studies into diet and risk of chronic diseases. European Investigation into Cancer and Nutrition. Ann Nutr Metab. 1999, 43: 195-204. 10.1159/000012786.CrossRefPubMed Boeing H, Wahrendorf J, Becker N: EPIC-Germany – A source for studies into diet and risk of chronic diseases. European Investigation into Cancer and Nutrition. Ann Nutr Metab. 1999, 43: 195-204. 10.1159/000012786.CrossRefPubMed
15.
go back to reference Riboli E, Hunt KJ, Slimani N, Ferrari P, Norat T, Fahey M, Charrondiere UR, Hemon B, Casagrande C, Vignat J, Overvad K, Tjonneland A, Clavel-Chapelon F, Thiebaut A, Wahrendorf J, Boeing H, Trichopoulos D, Trichopoulou A, Vineis P, Palli D, Bueno-De-Mesquita HB, Peeters PH, Lund E, Engeset D, Gonzalez CA, Barricarte A, Berglund G, Hallmans G, Day NE, Key TJ, Kaaks R, Saracci R: European Prospective Investigation into Cancer and Nutrition (EPIC): study populations and data collection. Public Health Nutr. 2002, 5: 1113-1124. 10.1079/PHN2002394.CrossRefPubMed Riboli E, Hunt KJ, Slimani N, Ferrari P, Norat T, Fahey M, Charrondiere UR, Hemon B, Casagrande C, Vignat J, Overvad K, Tjonneland A, Clavel-Chapelon F, Thiebaut A, Wahrendorf J, Boeing H, Trichopoulos D, Trichopoulou A, Vineis P, Palli D, Bueno-De-Mesquita HB, Peeters PH, Lund E, Engeset D, Gonzalez CA, Barricarte A, Berglund G, Hallmans G, Day NE, Key TJ, Kaaks R, Saracci R: European Prospective Investigation into Cancer and Nutrition (EPIC): study populations and data collection. Public Health Nutr. 2002, 5: 1113-1124. 10.1079/PHN2002394.CrossRefPubMed
16.
go back to reference Boeing H, Korfmann A, Bergmann MM: Recruitment procedures of EPIC-Germany. European Investigation into Cancer and Nutrition. Ann Nutr Metab. 1999, 43: 205-215. 10.1159/000012787.CrossRefPubMed Boeing H, Korfmann A, Bergmann MM: Recruitment procedures of EPIC-Germany. European Investigation into Cancer and Nutrition. Ann Nutr Metab. 1999, 43: 205-215. 10.1159/000012787.CrossRefPubMed
17.
go back to reference National Institutes of Health: Third Report of the National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Executive Summary. 2001, Bethesda, MD: National Institutes of Health, National Heart, Lung, and Blood Institute; (NIH Publication No. 01-3670) National Institutes of Health: Third Report of the National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Executive Summary. 2001, Bethesda, MD: National Institutes of Health, National Heart, Lung, and Blood Institute; (NIH Publication No. 01-3670)
18.
go back to reference Grundy SM, Brewer HB, Cleeman JI, Smith SC, Lenfant C: Definition of metabolic syndrome: report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Circulation. 2004, 109: 433-438. 10.1161/01.CIR.0000111245.75752.C6.CrossRefPubMed Grundy SM, Brewer HB, Cleeman JI, Smith SC, Lenfant C: Definition of metabolic syndrome: report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Circulation. 2004, 109: 433-438. 10.1161/01.CIR.0000111245.75752.C6.CrossRefPubMed
19.
go back to reference Klipstein-Grobusch K, Georg T, Boeing H: Interviewer variability in anthropometric measurements and estimates of body composition. Int J Epidemiol. 1997, 26 (Suppl 1): S174-180. 10.1093/ije/26.suppl_1.S174.CrossRefPubMed Klipstein-Grobusch K, Georg T, Boeing H: Interviewer variability in anthropometric measurements and estimates of body composition. Int J Epidemiol. 1997, 26 (Suppl 1): S174-180. 10.1093/ije/26.suppl_1.S174.CrossRefPubMed
20.
go back to reference Kroke A, Bergmann MM, Lotze G, Jeckel A, Klipstein-Grobusch K, Boeing H: Measures of quality control in the German component of the EPIC study. European Prospective Investigation into Cancer and Nutrition. Ann Nutr Metab. 1999, 43: 216-224. 10.1159/000012788.CrossRefPubMed Kroke A, Bergmann MM, Lotze G, Jeckel A, Klipstein-Grobusch K, Boeing H: Measures of quality control in the German component of the EPIC study. European Prospective Investigation into Cancer and Nutrition. Ann Nutr Metab. 1999, 43: 216-224. 10.1159/000012788.CrossRefPubMed
21.
go back to reference Prentice RL: A case-cohort design for epidemiologic cohort studies and disease prevention trials. Biometrika. 1986, 73: 1-11. 10.1093/biomet/73.1.1.CrossRef Prentice RL: A case-cohort design for epidemiologic cohort studies and disease prevention trials. Biometrika. 1986, 73: 1-11. 10.1093/biomet/73.1.1.CrossRef
22.
go back to reference Wang JJ, Hu G, Miettinen ME, Tuomilehto J: The metabolic syndrome and incident diabetes: assessment of four suggested definitions of the metabolic syndrome in a Chinese population with high post-prandial glucose. Horm Metab Res. 2004, 36: 708-715. 10.1055/s-2004-826020.CrossRefPubMed Wang JJ, Hu G, Miettinen ME, Tuomilehto J: The metabolic syndrome and incident diabetes: assessment of four suggested definitions of the metabolic syndrome in a Chinese population with high post-prandial glucose. Horm Metab Res. 2004, 36: 708-715. 10.1055/s-2004-826020.CrossRefPubMed
23.
go back to reference Sattar N, Gaw A, Scherbakova O, Ford I, O'Reilly DS, Haffner SM, Isles C, Macfarlane PW, Packard CJ, Cobbe SM, Shepherd J: Metabolic syndrome with and without C-reactive protein as a predictor of coronary heart disease and diabetes in the West of Scotland Coronary Prevention Study. Circulation. 2003, 108: 414-419. 10.1161/01.CIR.0000080897.52664.94.CrossRefPubMed Sattar N, Gaw A, Scherbakova O, Ford I, O'Reilly DS, Haffner SM, Isles C, Macfarlane PW, Packard CJ, Cobbe SM, Shepherd J: Metabolic syndrome with and without C-reactive protein as a predictor of coronary heart disease and diabetes in the West of Scotland Coronary Prevention Study. Circulation. 2003, 108: 414-419. 10.1161/01.CIR.0000080897.52664.94.CrossRefPubMed
24.
go back to reference Wilson PW, D'Agostino RB, Parise H, Sullivan L, Meigs JB: Metabolic syndrome as a precursor of cardiovascular disease and type 2 diabetes mellitus. Circulation. 2005, 112: 3066-3072. 10.1161/CIRCULATIONAHA.105.539528.CrossRefPubMed Wilson PW, D'Agostino RB, Parise H, Sullivan L, Meigs JB: Metabolic syndrome as a precursor of cardiovascular disease and type 2 diabetes mellitus. Circulation. 2005, 112: 3066-3072. 10.1161/CIRCULATIONAHA.105.539528.CrossRefPubMed
25.
go back to reference Wannamethee SG, Shaper AG, Lennon L, Morris RW: Metabolic syndrome vs Framingham Risk Score for prediction of coronary heart disease, stroke, and type 2 diabetes mellitus. Arch Intern Med. 2005, 165: 2644-2650. 10.1001/archinte.165.22.2644.CrossRefPubMed Wannamethee SG, Shaper AG, Lennon L, Morris RW: Metabolic syndrome vs Framingham Risk Score for prediction of coronary heart disease, stroke, and type 2 diabetes mellitus. Arch Intern Med. 2005, 165: 2644-2650. 10.1001/archinte.165.22.2644.CrossRefPubMed
26.
go back to reference Elwood PC, Pickering JE, Fehily AM: Milk and dairy consumption, diabetes and the metabolic syndrome: the Caerphilly prospective study. J Epidemiol Community Health. 2007, 61: 695-698. 10.1136/jech.2006.053157.PubMedCentralCrossRefPubMed Elwood PC, Pickering JE, Fehily AM: Milk and dairy consumption, diabetes and the metabolic syndrome: the Caerphilly prospective study. J Epidemiol Community Health. 2007, 61: 695-698. 10.1136/jech.2006.053157.PubMedCentralCrossRefPubMed
27.
go back to reference Macchia A, Levantesi G, Borrelli G, Franzosi MG, Maggioni AP, Marfisi R, Scarano M, Tavazzi L, Tognoni G, Valagussa F, Marchioli R, Associazione Nazionale Medici Cardiologi Ospedalieri; Istituto di Ricerche Farmacologiche Mario Negri-Consorzio Mario Negri Sud, Santa Maria Imbaro; Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto miocardico (GISSI)-Prevenzione Investigators: A clinically practicable diagnostic score for metabolic syndrome improves its predictivity of diabetes mellitus: the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto miocardico (GISSI)-Prevenzione scoring. Am Heart J. 2006, 151: 754.e7-754.e17. 10.1016/j.ahj.2005.10.023.CrossRef Macchia A, Levantesi G, Borrelli G, Franzosi MG, Maggioni AP, Marfisi R, Scarano M, Tavazzi L, Tognoni G, Valagussa F, Marchioli R, Associazione Nazionale Medici Cardiologi Ospedalieri; Istituto di Ricerche Farmacologiche Mario Negri-Consorzio Mario Negri Sud, Santa Maria Imbaro; Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto miocardico (GISSI)-Prevenzione Investigators: A clinically practicable diagnostic score for metabolic syndrome improves its predictivity of diabetes mellitus: the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto miocardico (GISSI)-Prevenzione scoring. Am Heart J. 2006, 151: 754.e7-754.e17. 10.1016/j.ahj.2005.10.023.CrossRef
28.
go back to reference Rothman K, Greenland S: Modern Epidemiology. 1998, Philadelphia: Lippincott-Raven, 2 Rothman K, Greenland S: Modern Epidemiology. 1998, Philadelphia: Lippincott-Raven, 2
Metadata
Title
Metabolic syndrome and risk of incident diabetes: findings from the European Prospective Investigation into Cancer and Nutrition-Potsdam Study
Authors
Earl S Ford
Matthias B Schulze
Tobias Pischon
Manuela M Bergmann
Hans-Georg Joost
Heiner Boeing
Publication date
01-12-2008
Publisher
BioMed Central
Published in
Cardiovascular Diabetology / Issue 1/2008
Electronic ISSN: 1475-2840
DOI
https://doi.org/10.1186/1475-2840-7-35

Other articles of this Issue 1/2008

Cardiovascular Diabetology 1/2008 Go to the issue